Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation

Himadri B. Thapa, Christina A. Passegger, Dominik Fleischhacker, Paul Kohl, Yi-Chi Chen, Ratchara Kalawong, Carmen Tam-Amersdorfer, Michael R. Gerstorfer, Jana Strahlhofer, Kristina Schild-Prüfert, Ellen L. Zechner, Andreas Blesl, Lukas Binder, Georg A. Busslinger, Leo Eberl, Gregor Gorkiewicz, Herbert Strobl, Christoph Högenauer () and Stefan Schild ()
Additional contact information
Himadri B. Thapa: University of Graz
Christina A. Passegger: Medical University of Graz
Dominik Fleischhacker: University of Graz
Paul Kohl: University of Graz
Yi-Chi Chen: University of Zurich
Ratchara Kalawong: University of Zurich
Carmen Tam-Amersdorfer: Medical University of Graz
Michael R. Gerstorfer: Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences
Jana Strahlhofer: University of Graz
Kristina Schild-Prüfert: University of Graz
Ellen L. Zechner: University of Graz
Andreas Blesl: Medical University of Graz
Lukas Binder: Medical University of Graz
Georg A. Busslinger: Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences
Leo Eberl: University of Zurich
Gregor Gorkiewicz: BioTechMed
Herbert Strobl: Medical University of Graz
Christoph Högenauer: BioTechMed
Stefan Schild: University of Graz

Nature Communications, 2025, vol. 16, issue 1, 1-22

Abstract: Abstract The gut microbiome contributes to chronic inflammatory responses in ulcerative colitis (UC), but molecular mechanisms and disease-relevant effectors remain unclear. Here we analyze the pro-inflammatory properties of colonic fluid obtained during colonoscopy from UC and control patients. In patients with UC, we find that the pelletable effector fraction is composed mostly of bacterial extracellular vesicles (BEVs) that exhibit high IgA-levels and incite strong pro-inflammatory responses in IgA receptor-positive (CD89+) immune cells. Biopsy analyses reveal higher infiltration of CD89+ immune cells in the colonic mucosa from patients with UC than control individuals. Further studies show that IgA-coated BEVs, but not host-derived vesicles nor soluble IgA, are potent activators of pro-inflammatory responses in CD89+ cells. IgA-coated BEVs also exacerbate intestinal inflammation in a dextran sodium sulfate colitis model using transgenic mice expressing human CD89. Our data thus implicate a link between IgA-coated BEVs and intestinal inflammation via CD89+ immune cells, and also hint a potential new therapeutic target for UC.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-59354-5 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59354-5

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-59354-5

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().